Concord Biotech (CONCORDBIO) Shareholding Pattern

NSE: CONCORDBIO • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 44.08%
FII Holding 7.58%
DII Holding 9.58%
Public Holding 8.11%
Total Shareholders 81,815
As of Dec 2025
View the latest shareholding pattern of Concord Biotech (CONCORDBIO) including promoter, FII, DII, and public holdings. Track CONCORDBIO ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See CONCORDBIO yearly price range)

Concord Biotech (CONCORDBIO) Shareholding Summary

  • Promoter holding remains unchanged at 44.08% in Dec 2025
  • FII/FPI have decreased holdings from 8.03% to 7.58% in Dec 2025
  • DIIs have increased holdings from 9.55% to 9.58% in Dec 2025
  • Institutional investors have decreased holdings from 17.58% to 17.16% in Dec 2025
  • Public holding has increased from 7.77% to 8.11% in Dec 2025
  • Number of shareholders decreased from 82,650 to 81,815 in Dec 2025

CONCORDBIO Quarterly Ownership Changes

Quarter-over-quarter changes for Concord Biotech from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
-0.45%
DII Holding Change
Sept 2025 to Dec 2025
+0.03%
Public Holding Change
Sept 2025 to Dec 2025
+0.34%

Concord Biotech (CONCORDBIO) Quarterly Shareholding Trends

Visual breakdown of CONCORDBIO ownership distribution over time. Learn more about CONCORDBIO dividend growth.

Promoter
FII
DII
Public
Government

Rising institutional holdings in CONCORDBIO often correlate with improved fundamentals. Check out CONCORDBIO stock price history.

Concord Biotech (CONCORDBIO) Shareholding Data

Download complete CONCORDBIO ownership data for offline analysis. Discover CONCORDBIO quarterly financials.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 44.08% 7.58% 9.58% 0.00% 8.11% 30.64% 99.99% 81,815
Sept 2025 44.08% 8.03% 9.55% 0.00% 7.77% 30.56% 99.99% 82,650
Jun 2025 44.08% 9.11% 8.87% 0.00% 7.43% 30.51% 100.00% 82,045
Mar 2025 44.08% 9.35% 9.16% 0.00% 6.94% 30.47% 100.00% 81,219
Dec 2024 44.08% 8.33% 9.66% 0.00% 7.33% 30.59% 99.99% 82,004
Sept 2024 44.08% 8.10% 9.89% 0.00% 7.33% 30.61% 100.01% 84,298
Jun 2024 44.08% 7.11% 10.40% 0.00% 7.64% 30.76% 99.99% 80,737
Mar 2024 44.08% 6.48% 8.46% 0.00% 7.08% 33.90% 100.00% 83,296
Dec 2023 44.08% 0.00% 8.13% 0.00% 6.76% 41.03% 100.00% 87,486
Sept 2023 44.08% 7.30% 8.18% 0.00% 6.78% 33.66% 100.00% 100,927
Aug 2023 44.08% 0.00% 4.89% 0.00% 13.33% 37.69% 99.99% 377,572

CONCORDBIO promoter holding above 50% indicates strong insider confidence. Explore the Concord Biotech P/E valuation for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 44.08% 7.58% 9.58% 0.00% 8.11% 30.64% 99.99% 81,815
Sept 2025 44.08% 8.03% 9.55% 0.00% 7.77% 30.56% 99.99% 82,650
Jun 2025 44.08% 9.11% 8.87% 0.00% 7.43% 30.51% 100.00% 82,045
Mar 2025 44.08% 9.35% 9.16% 0.00% 6.94% 30.47% 100.00% 81,219
Dec 2024 44.08% 8.33% 9.66% 0.00% 7.33% 30.59% 99.99% 82,004
Sept 2024 44.08% 8.10% 9.89% 0.00% 7.33% 30.61% 100.01% 84,298
Jun 2024 44.08% 7.11% 10.40% 0.00% 7.64% 30.76% 99.99% 80,737
Mar 2024 44.08% 6.48% 8.46% 0.00% 7.08% 33.90% 100.00% 83,296
Dec 2023 44.08% 0.00% 8.13% 0.00% 6.76% 41.03% 100.00% 87,486
Sept 2023 44.08% 7.30% 8.18% 0.00% 6.78% 33.66% 100.00% 100,927
Aug 2023 44.08% 0.00% 4.89% 0.00% 13.33% 37.69% 99.99% 377,572

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 44.08% 7.58% 9.58% 0.00% 8.11% 30.64% 99.99% 81,815
Dec 2024 44.08% 8.33% 9.66% 0.00% 7.33% 30.59% 99.99% 82,004
Dec 2023 44.08% 0.00% 8.13% 0.00% 6.76% 41.03% 100.00% 87,486

Year-over-year trends reveal long-term ownership shifts.

Understanding Concord Biotech (CONCORDBIO) Shareholding Pattern

Concord Biotech shareholding pattern reveals who owns CONCORDBIO stock and how ownership changes over time. High promoter stakes in CONCORDBIO often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your CONCORDBIO trades. CONCORDBIO quarterly trends

Combine CONCORDBIO ownership analysis with price movements and financial performance for a complete investment picture. (See CONCORDBIO DCF)